Table 2.
Group Effects (HC, CHR, ESZ)a | Conversion Group Effects (Converter, Non-converter)b |
|||||||
---|---|---|---|---|---|---|---|---|
Effect | df | F | p-value | Follow-Up Testsc | df | F | p-value | Follow-Up Testsc |
Group | 2, 98 | 8.63 | <.001 | CHR>HC*, ESZ>HC***, CHR=ESZ | 1,29 | 4.07 | 0.053 | Converter>Non-converter* |
Deviant Type (DUR, FREQ, DBL) | 2,196 | 0.37 | 0.639 | 2, 58 | 0.74 | 0.441 | ||
Fronto-Central Lead (Frontal, Central) | 1,98 | 0.02 | 0.889 | 1,29 | 1.66 | 0.208 | ||
Lateral Lead (Left, Midline, Right) | 2,196 | 1.61 | 0.205 | 2,58 | 6.45 | 0.009 | Left>Midline*, Midline>Right* | |
Group x Deviant Type | 4,196 | 0.67 | 0.579 | 2, 58 | 0.57 | 0.512 | ||
Group x Fronto-Central Lead | 2,98 | 2.38 | 0.098 | 1,29 | 0.10 | 0.756 | ||
Group x Lateral Lead | 4,196 | 2.52 | 0.053 | 2, 58 | 1.26 | 0.284 | ||
Lateral Lead effect in HC | 2, 86 | 0.00 | 1.000 | |||||
Lateral Lead effect in CHR | 2,74 | 7.73 | 0.004 | Left>Midline*, Midline>Right* | ||||
Lateral Lead effect in ESZ | 2,36 | 0.21 | 0.747 | |||||
Group effect at Left (F3, C3) leads | 2,98 | 10.23 | <.001 | CHR>HC***, ESZ>HC***, CHR=ESZ | ||||
Group effect at Midline (Fz, Cz) leads | 2, 98 | 8.25 | <.001 | CHR>HC*, ESZ>HC***, CHR=ESZ | ||||
Group effect at Right (F4, C4) leads | 2, 98 | 6.62 | 0.002 | CHR=HC, ESZ>HC**, CHR=ESZ | ||||
Group x Lateral Lead x Deviant Type | 8,392 | 1.15 | 0.330 | 4,116 | 0.52 | 0.681 | ||
Group x Fronto-Central Lead x Deviant Type | 4,196 | 2.50 | 0.054 | 2,58 | 1.54 | 0.226 | ||
Group x Fronto-Central Lead for DUR | 1,98 | 1.27 | 0.285 | |||||
Group x Fronto-Central Lead for DBL | 1,98 | 1.75 | 0.180 | |||||
Group x Fronto-Central Lead for FREQ | 1,98 | 4.39 | 0.015 | |||||
Fronto-Central Lead effect in HC | 1,43 | 0.00 | 0.999 | |||||
Fronto-Central Lead effect in ESZ | 1,18 | 0.24 | 0.627 | |||||
Fronto-Central Lead effect in CHR | 1,37 | 9.67 | 0.004 | Frontal>Central** | ||||
Group effect at Frontal Leads | 2,98 | 5.59 | 0.005 | CHR>HC*, ESZ>HC*, CHR=ESZ | ||||
Group effect at Central Leads | 2,98 | 3.64 | 0.030 | CHR=HC, ESZ>HC*, CHR=ESZ | ||||
Fronto-Central Lead x Deviant Type in HC | 2,86 | 0.00 | 1.000 | |||||
Fronto-Central Lead x Deviant Type in ESZ | 2,36 | 1.67 | 0.204 | |||||
Fronto-Central Lead x Deviant Type in CHR | 2,74 | 7.31 | 0.003 | |||||
Deviant Type effect at Frontal Leads | 2,74 | 2.51 | 0.108 | |||||
Deviant Type effect at Central Leads | 2,74 | 0.78 | 0.461 | |||||
Fronto-Central Lead effect for DUR | 1,37 | 0.34 | 0.566 | |||||
Fronto-Central Lead effect for FREQ | 1,37 | 9.67 | 0.004 | Frontal>Central** | ||||
Fronto-Central Lead effect for DBL | 1,37 | 2.63 | 0.113 | |||||
Group x Deviant Type at Frontal Leads | 2,196 | 0.99 | 0.401 | |||||
Group x Deviant Type at Central Leads | 2,196 | 0.61 | 0.621 | |||||
Group x Fronto-Central Lead x Lateral Lead | 4,196 | 1.75 | 0.148 | 2, 58 | 3.87 | 0.035 | ||
Group x Fronto-Central Lead effect on Left | 1,29 | 0.24 | 0.629 | |||||
Group x Fronto-Central Lead effect on Midline | 1,29 | 1.31 | 0.262 | |||||
Group x Fronto-Central Lead effect on Right | 1,29 | 0.40 | 0.535 | |||||
Group x Lateral Lead effect at Frontal leads | 1,29 | 0.19 | 0.764 | |||||
Group x Lateral Lead effect at Central leads | 1,29 | 2.37 | 0.122 | |||||
Fronto-Central Lead x Lateral Lead in Nonconverters | 1,15 | 2.25 | 0.132 | |||||
Fronto-Central Lead x Lateral Lead in Converters | 1,14 | 5.55 | 0.016 | |||||
Lateral Lead effect at Frontal leads | 2,28 | 3.59 | 0.051 | Left=Midline, Midline>Right* | ||||
Lateral Lead effect at Central leads | 2,28 | 3.58 | 0.049 | Left>Midline*, Midline=Right | ||||
Fronto-central Lead effect on Left | 1,14 | 0.44 | 0.518 | |||||
Fronto-central Lead effect on Midline | 1,14 | 4.95 | 0.043 | Frontal>Central* | ||||
Fronto-central Lead effect on Right | 1,14 | 0.19 | 0.670 | |||||
Group x Deviant Type x Fronto-Central x Lateral Lead | 8,392 | 0.94 | 0.476 | 4,116 | 0.73 | 0.537 |
Repeated measures ANOVA comparing Healthy Control (HC), Clinical High Risk (CHR), and Early Illness Schizophrenia (ESZ) groups across the three deviant types (DUR, FREQ, DBL) using age-corrected mismatch negativity (MMN) z-scores. DUR=Duration deviant type; FREQ=Frequency deviant type; DBL=Double-deviant type.
Repeated measures ANOVA comparing converters and non-converters to psychosis across DUR, FREQ, and DBL deviant types using age-corrected MMN z-scores. More positive MMN z-scores indicate greater MMN deficits relative to HC.
Between group comparisons are based on post-hoc Tukey tests. Between lead comparisons are based on Helmert contrasts.
p ≤ 0.05,
p ≤ 0.01,
p ≤ 0.001